| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/27/2004 | US20040102377 An infant nutritional composition contains a protein with casein rich in transforming growth factor, promoting the antigen tolerance in mouth |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040102375 Methods to overcome inhibition of growth cone translocation |
| 05/27/2004 | US20040102374 Methods for controlling the lysis of coagulated blood with apolipoprotein e4 theno type |
| 05/27/2004 | US20040102373 Protein-induced morphogenesis |
| 05/27/2004 | US20040102372 Therapeutic antiangiogenic compositions and methods |
| 05/27/2004 | US20040102371 Encoded amino acid sequences, DNAs encoding the proteins, recombinant vectors, culturing, drugs comprising the proteins or DNAs, antibodies, drug screening, for arteriosclerosis, hyperlipidemia, obesity or mellitus diabetes |
| 05/27/2004 | US20040102370 Peptides that stimulate cell survival and axon regeneration |
| 05/27/2004 | US20040102369 Transport of basic fibroblast growth factor across the blood brain barrier |
| 05/27/2004 | US20040102368 Methods of treating cerebral ischemia |
| 05/27/2004 | US20040102366 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids |
| 05/27/2004 | US20040102365 Pharmaceutical composition for prevention and remedy of osteoporosis |
| 05/27/2004 | US20040102364 A radioactive cyclized peptide has chemical and metabolic stability, bioavailability, pharmacokinetics; drugs for treating cancers, autoimmune diseases, endocrine disorders, diabetes, gastrointestinal disorders, inflammatory diseases |
| 05/27/2004 | US20040102363 Substantially pure lectin for prevention and treatment of crustaceous infected by baculovirus, a food composition containing the lectin and a method for increasing the crustaceous resistance to infections |
| 05/27/2004 | US20040102362 Protocol for paracentesis |
| 05/27/2004 | US20040101965 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/27/2004 | US20040101963 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus |
| 05/27/2004 | US20040101956 For drug screening kits; therapy/prophylaxis; genetic engineering |
| 05/27/2004 | US20040101943 Nucleic acid modification enzymes |
| 05/27/2004 | US20040101941 Intracellular delivery system for protein phosphatases |
| 05/27/2004 | US20040101940 Identification of a new cytotoxic activity from the ink of aplysia punctata |
| 05/27/2004 | US20040101934 Beverage comprising peptide nerve growth factor conjugate for use in treatment of pain; analgesics; tranquilizers |
| 05/27/2004 | US20040101931 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 05/27/2004 | US20040101927 Comprises nucleotide sequences coding polypeptides for diagnosis, prognosis, prevention and treatment of neurodegenerative and cancer disorders |
| 05/27/2004 | US20040101919 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections |
| 05/27/2004 | US20040101916 Using decreased expression of growth arrest and DNA-damage-inducible gene 45 beta (GADD45 beta) to diagnose cirrhosis and liver cancer |
| 05/27/2004 | US20040101911 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/27/2004 | US20040101910 Immunoglobulin capable of binding lymphocyte polypeptides for treatment and prevention of cell proliferative disorders; antitumor agents |
| 05/27/2004 | US20040101907 Characterization of the gsk-3beta protein and methods of use thereof |
| 05/27/2004 | US20040101899 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/27/2004 | US20040101896 NIMA interacting proteins |
| 05/27/2004 | US20040101884 Molecules for disease detection and treatment |
| 05/27/2004 | US20040101883 Adenylyl and guanylyl cyclases |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101875 Novel g protein-coupled receptor protein and dna thereof |
| 05/27/2004 | US20040101858 Modulation of hypoxia-inducible factor 1 alpha expression |
| 05/27/2004 | US20040101857 Modulation of cytokine-inducible kinase expression |
| 05/27/2004 | US20040101856 Antisense nucleotide sequences for treatment of hyperproliferative disorders |
| 05/27/2004 | US20040101852 Antisense nucleotide sequences for treatment of neurodegenerative diseases |
| 05/27/2004 | US20040101850 Antisense nucleotide sequences for treatment of hyperactive immune response disorders |
| 05/27/2004 | US20040101849 Modulation of selenoprotein W expression |
| 05/27/2004 | US20040101848 Antisense nucleotide sequences for treatment of hyperproliferative disorders |
| 05/27/2004 | US20040101847 Antisense nucleotide sequences for treatment of autoimmune diseases |
| 05/27/2004 | US20040101585 Preparation of crystallized metal containing protein for use in the treatment of cell proliferative disorders; antiproliferative/anticarcinogenic agents |
| 05/27/2004 | US20040101580 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 05/27/2004 | US20040101576 Preventing ultraviolet light-induced skin immunosuppression, glutathione or Scutellaria root extract, prevent a reduction of immune functions due to ultraviolet light. |
| 05/27/2004 | US20040101562 Enzyme encapsulated in hydrophilic low melting polymer; bioavailability |
| 05/27/2004 | US20040101552 Pharmaceutical compositions |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | US20040101525 Heat resistance; controlling Clostridium, Campylobacter, Streptococcus; gastrointestinal disorders; bactericides |
| 05/27/2004 | US20040101524 Genetically engineered; treatment of mucopolysaccharidosis VI (MPS V1) or Maroteaux-Lamy syndrome; purity measured using reverse-phase high performance liquid chromatography |
| 05/27/2004 | US20040101521 Reducing concentration of iron in animal tissue by complexing, chelation |
| 05/27/2004 | US20040101512 Adenoviral vectors for treating disease |
| 05/27/2004 | US20040101511 Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| 05/27/2004 | US20040101510 Chemokine PARC suppresses specific cytokine production |
| 05/27/2004 | US20040101509 Chemokine mutants in the treatment of multiple sclerosis |
| 05/27/2004 | US20040101485 Kidney and liver diseases; antiarthritic agents; antidepressants; Alzheimer's disease; Parkinson's disease; cardiovascular disorders; anticancer agents |
| 05/27/2004 | DE10252719A1 New tubulysin analogs, useful for treating tumor or cancer diseases, immunologically induced or autoimmune diseases, inflammatory diseases or rheumatoid arthritis or for surface modification of implants |
| 05/27/2004 | DE10147638B4 Leukozyten-Inaktivierungs-Modul (LIM) Leukocyte inactivation module (LIM) |
| 05/27/2004 | CA2757475A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | CA2505949A1 Process for designing inhibitors of influenza virus non-structural protein 1 |
| 05/27/2004 | CA2505931A1 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | CA2505868A1 Ligands |
| 05/27/2004 | CA2505810A1 Stable aerosol formulation of peptides and protein with non-cfc propellants |
| 05/27/2004 | CA2505801A1 Antisense modulation of apolipoprotein b expression |
| 05/27/2004 | CA2505558A1 T cell receptor display |
| 05/27/2004 | CA2505523A1 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 05/27/2004 | CA2505478A1 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| 05/27/2004 | CA2505250A1 Acetylated hmgb1 protein |
| 05/27/2004 | CA2505126A1 Soluble oral patch with collagen and interlaced active ingredients |
| 05/27/2004 | CA2505118A1 Calmodulin independent activation of nitric oxide synthase by nadph analogs |
| 05/27/2004 | CA2505091A1 Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil |
| 05/27/2004 | CA2505003A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 05/27/2004 | CA2504956A1 Botulinum toxin formulations for oral administration |
| 05/27/2004 | CA2504953A1 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504768A1 Compounds and methods for modulating functions of classical cadherins |
| 05/27/2004 | CA2504508A1 Methods and compositions for prostate epithelial cell differentiation |
| 05/27/2004 | CA2504480A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism |
| 05/27/2004 | CA2504226A1 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 05/27/2004 | CA2503759A1 Compositions and methods for the treatment of rheumatoid arthritis |
| 05/27/2004 | CA2503748A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | CA2503672A1 Growth hormone variations in humans and its uses |
| 05/27/2004 | CA2503303A1 Flavivirus fusion inhibitors |
| 05/27/2004 | CA2502928A1 Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 05/27/2004 | CA2502363A1 Irrigation solution and method for inhibition of tumor cell adhesion, pain and inflammation |
| 05/27/2004 | CA2502251A1 Method of treatment of psychological conditions by administration of nerve growth factor |
| 05/27/2004 | CA2499463A1 Compositions and methods for prolonging survival of platelets |
| 05/27/2004 | CA2497268A1 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/27/2004 | CA2483693A1 Identification of oligoadenylate synthetase-like genes |
| 05/26/2004 | EP1422241A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 05/26/2004 | EP1422240A2 Analogs of nociceptin |
| 05/26/2004 | EP1422239A2 Mobilization of hematopoietic stem cells using a chemokine |
| 05/26/2004 | EP1422238A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 05/26/2004 | EP1422237A2 Methods for the recombinant production of antifusogenic peptides |
| 05/26/2004 | EP1421956A1 Process for stepwise attachment of polyethylene glycol (PEG) to a polypeptide |
| 05/26/2004 | EP1421954A1 Materials sustainedly releasing drug in vivo |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421950A1 Method of treating left ventricular dysfunction |
| 05/26/2004 | EP1421949A1 Hepatitis b virus proliferation inhibitor |